--2024/Q4-- / 3.790B--
Oct 31, 20242024/Q3-- / 3.658B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
Feb 2, 20242023/Q43.434B / 3.287B--
US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 1017.560
- +3.310+0.33%
Trading Oct 15 11:26 ET
112.17BMarket Cap26.94P/E (TTM)
1024.360High1003.790Low120.83KVolume1016.830Open1014.250Pre Close122.74MTurnover0.11%Turnover Ratio29.27P/E (Static)110.23MShares1211.20052wk High3.98P/B107.60BFloat Cap769.19052wk Low--Dividend TTM105.75MShs Float1211.200Historical High--Div YieldTTM2.03%Amplitude4.610Historical Low1015.863Avg Price1Lot Size
Regeneron Pharmaceuticals Key Stats
Regeneron Pharmaceuticals Q3 2024 Estimates Date
Currency：USDOct 31, 2024
| Estimate | YoY | |
| Revenue | 3.66B | +8.77% |
| EPS | 9.37 | +5.41% |
Analyst Rating
Oct 15, 2024
Regeneron Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Regeneron Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
